This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: The Innovations of Johannes A. Kok
Introduction
Johannes A. Kok is a notable inventor based in AB Soest, Netherlands. He has made significant contributions to the field of veterinary medicine, particularly through his innovative work on vaccines. His expertise and dedication have led to the development of a unique combined vaccine that addresses critical health issues in poultry.
Latest Patents
Johannes A. Kok holds a patent for a combined, inactivated vaccine that is ready for administration and effective against Newcastle disease and egg production drop caused by adeno-like viruses. The patent details a process for preparing this vaccine by combining a Newcastle disease virus (NDV) containing liquid with an adeno-like virus (ALV) containing liquid. This innovative approach involves the use of an oil phase with essential components such as light paraffinic mineral oils, vegetable oils, and emulsifiers derived from various sources. The meticulous preparation process ensures the vaccine's efficacy and safety for use in poultry.
Career Highlights
Throughout his career, Johannes A. Kok has been associated with Roussel Uclaf, a prominent company in the pharmaceutical industry. His work has focused on developing solutions that enhance animal health and productivity. His contributions have been instrumental in advancing veterinary vaccine technology.
Collaborations
Johannes A. Kok has collaborated with Peter Apontoweil, working together to innovate and improve vaccine formulations. Their partnership has fostered advancements in the field, leading to better health outcomes for poultry.
Conclusion
Johannes A. Kok's innovative work in vaccine development has made a significant impact on veterinary medicine. His dedication to improving animal health through scientific advancements is commendable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile